Vigonvita Life Sciences Co Ltd

Company Profile

• Business description

  Vigonvita Life Sciences Co Ltd biopharmaceutical company. It is focused on innovation driven biopharmaceutical development, with a strategic emphasis on addressing unmet clinical needs in the treatment of neuropsychiatric, infectious, and andrological diseases. The company's core Products include LV232, anti-depression drug candidate, VV913: a novel investigational drug candidate for premature ejaculation and, VV116: an oral nucleoside analog with broad-spectrum antiviral potential. The company's operations are located in the PRC and Uzbekistan. Revenue is generated from the out-licensing and the sales of its pharmaceutical products.

• Contact

  No. 108, Yuxin Road
  8th Floor, Building A
  Suzhou Industrial Park District
  Suzhou215123
  CHN

  T: +86 51262898861

  https://www.vigonvita.cn

• Sector

  Healthcare

  Stock type

  Defensive

• Industry

  Drug Manufacturers - General

  Fiscal Year End

  31 December 2026

  Employees

  315